These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27173934)

  • 21. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
    Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.
    Lambelé M; Koppensteiner H; Symeonides M; Roy NH; Chan J; Schindler M; Thali M
    J Virol; 2015 Mar; 89(6):3247-55. PubMed ID: 25568205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
    van Stigt Thans T; Akko JI; Niehrs A; Garcia-Beltran WF; Richert L; Stürzel CM; Ford CT; Li H; Ochsenbauer C; Kappes JC; Hahn BH; Kirchhoff F; Martrus G; Sauter D; Altfeld M; Hölzemer A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu.
    Hasan Z; Carlson JM; Gatanaga H; Le AQ; Brumme CJ; Oka S; Brumme ZL; Ueno T
    Biochem Biophys Res Commun; 2012 May; 421(2):291-5. PubMed ID: 22503975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.
    Ramirez PW; DePaula-Silva AB; Szaniawski M; Barker E; Bosque A; Planelles V
    Retrovirology; 2015 Jul; 12():65. PubMed ID: 26215564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
    Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
    J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.
    Xu Z; Lodge R; Power C; Cohen EA; Hobman TC
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.
    Bego MG; Côté É; Aschman N; Mercier J; Weissenhorn W; Cohen ÉA
    PLoS Pathog; 2015 Jul; 11(7):e1005024. PubMed ID: 26172439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity.
    Marchitto L; Tauzin A; Benlarbi M; Beaudoin-Bussières G; Dionne K; Bélanger É; Chatterjee D; Bourassa C; Medjahed H; Yang D; Chiu TJ; Chen HC; Iii ABS; Richard J; Finzi A
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses.
    Langer S; Hammer C; Hopfensperger K; Klein L; Hotter D; De Jesus PD; Herbert KM; Pache L; Smith N; van der Merwe JA; Chanda SK; Fellay J; Kirchhoff F; Sauter D
    Elife; 2019 Feb; 8():. PubMed ID: 30717826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Vpu does not degrade interferon regulatory factor 3.
    Hotter D; Kirchhoff F; Sauter D
    J Virol; 2013 Jun; 87(12):7160-5. PubMed ID: 23552418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.
    Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells.
    Thananchai H; Makadzange T; Maenaka K; Kuroki K; Peng Y; Conlon C; Rowland-Jones S; Dong T
    AIDS; 2009 Jan; 23(2):189-93. PubMed ID: 19098488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate.
    Hill MS; Ruiz A; Pacyniak E; Pinson DM; Culley N; Yen B; Wong SW; Stephens EB
    Virology; 2008 Feb; 371(1):86-97. PubMed ID: 17950774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.
    Manganaro L; de Castro E; Maestre AM; Olivieri K; García-Sastre A; Fernandez-Sesma A; Simon V
    J Virol; 2015 Oct; 89(19):9781-90. PubMed ID: 26178989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
    Rajapaksa US; Li D; Peng YC; McMichael AJ; Dong T; Xu XN
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13353-8. PubMed ID: 22826228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human immunodeficiency virus (HIV) Rev-binding protein (HRB) is a co-factor for HIV-1 Nef-mediated CD4 downregulation.
    Landi A; Timermans CG; Naessens E; Vanderstraeten H; Stove V; Verhasselt B
    J Gen Virol; 2016 Mar; 97(3):778-785. PubMed ID: 26701340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
    Sauter D; Hué S; Petit SJ; Plantier JC; Towers GJ; Kirchhoff F; Gupta RK
    Retrovirology; 2011 Dec; 8():103. PubMed ID: 22171785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
    Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.